United States of America based
Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered zinc finger DNA-binding proteins (ZFPs) as novel ZFP Therapeutics targeting various monogenic and infectious diseases with unmet medical needs.
TechnologiesGene Therapy Startups Pharmaceutical and Drug Discovery
No pipelines published yet
No services posted yet